Karashima, T., Komatsu, T., Yamamoto, S., Atagi, K., Hashida, H., Fukuhara, H., . . . Inoue, K. (2025). Transcutaneous Imiquimod Combined With Anti‐Programmed Cell Death‐1 Monoclonal Antibody Extends the Survival of Mice Bearing Renal Cell Carcinoma. Cancer Medicine, 14(10), . https://doi.org/10.1002/cam4.70966
Chicago-referens (17:e uppl.)Karashima, Takashi, et al. "Transcutaneous Imiquimod Combined With Anti‐Programmed Cell Death‐1 Monoclonal Antibody Extends the Survival of Mice Bearing Renal Cell Carcinoma." Cancer Medicine 14, no. 10 (2025). https://doi.org/10.1002/cam4.70966.
MLA-referens (9:e uppl.)Karashima, Takashi, et al. "Transcutaneous Imiquimod Combined With Anti‐Programmed Cell Death‐1 Monoclonal Antibody Extends the Survival of Mice Bearing Renal Cell Carcinoma." Cancer Medicine, vol. 14, no. 10, 2025, https://doi.org/10.1002/cam4.70966.
